Nwk Group, Inc. Eli Lilly & CO Transaction History

Nwk Group, Inc.

$242 Million
Q3 2024

A detailed history of Nwk Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Nwk Group, Inc. holds 15,800 shares of LLY stock, worth $12.4 Million. This represents 5.77% of its overall portfolio holdings.

Number of Shares

15,800

Previous 15,936 0.85%

Holding current value

$12.4 Million

Previous $14.4 Million 2.99%

% of portfolio

5.77%

Previous 6.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $105,011 - $130,562	-136 Reduced 0.85%	15,800 $14 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $97,857 - $122,720	-135 Reduced 0.84%	15,936 $14.4 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $227,404 - $304,235	384 Added 2.45%	16,071 $12.5 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $149,679 - $176,452	285 Added 1.85%	15,687 $9.14 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.23 Million - $1.7 Million	-2,832 Reduced 15.53%	15,402 $8.27 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $24,551 - $32,828	-70 Reduced 0.38%	18,234 $8.55 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $41,935 - $49,250	-135 Reduced 0.73%	18,304 $6.29 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $21,543 - $25,102	67 Added 0.36%	18,439 $6.75 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $184,707 - $210,493	-623 Reduced 3.28%	18,372 $5.94 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $53,516 - $62,835	192 Added 1.02%	18,995 $6.16 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $2.99 Million - $3.72 Million	12,751 Added 210.69%	18,803 $5.39 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.36 Million - $1.69 Million	6,052 New	6,052 $1.67 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nwk Group, Inc. with notifications on news.

Account